← Leaderboards
Michael Scott Mulligan
University Of Washington
$3,425,510
Attributed
$4,299,462
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $449.9K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,299,462 · 3
By mechanism
R01$1,923,667 · 1
U01$1,747,905 · 1
K08$627,890 · 1
Top collaborators
- Farhood Farjah4 shared
Most similar at University Of Washington
Same institution · by research overlap
- Edward Donald Verrier$3,637,079
- Lisa L Cunningham$2,377,881
- Alessandro Bitto$1,174,275
- Daniel R Storm$17,269,477
- Farhood Farjah$5,283,632
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungCell TypeAcuteEventLung TransplantationFunctional DisorderInsightCellsTransplant RecipientsTransplantationNatural ImmunityMediatingLung InjuryAlveolar MacrophagesCytokineAffectBacteriaCell Cell InteractionAreaAntigensAdaptor Signaling ProteinCerebrumBronchiolitis ObliteransBrain Hypoxia-Ischemia
Grant awards (14)
Lung transplant recipient exosome phenotypes and the risk of primary graft dysfunction and acute lung allograft dysfunction$433,531
U01 · FY2025 · HL · contact PI
Lung transplant recipient exosome phenotypes and the risk of primary graft dysfunction and acute lung allograft dysfunction$423,420
U01 · FY2024 · HL · contact PI
Lung transplant recipient exosome phenotypes and the risk of primary graft dysfunction and acute lung allograft dysfunction$441,074
U01 · FY2023 · HL · contact PI
Lung transplant recipient exosome phenotypes and the risk of primary graft dysfunction and acute lung allograft dysfunction$449,880
U01 · FY2022 · HL · contact PI
Role of TLR-4 in Lung Reperfusion Injury$367,567
R01 · FY2013 · HL · contact PI
Role of TLR-4 in Lung Reperfusion Injury$386,100
R01 · FY2012 · HL · contact PI
Role of TLR-4 in Lung Reperfusion Injury$390,000
R01 · FY2011 · HL · contact PI
Role of TLR-4 in Lung Reperfusion Injury$390,000
R01 · FY2010 · HL · contact PI
Role of TLR-4 in Lung Reperfusion Injury$390,000
R01 · FY2009 · HL · contact PI
Calcineurin Inhibition: Lung Reperfusion Injury$125,618
K08 · FY2006 · HL · contact PI
Calcineurin Inhibition: Lung Reperfusion Injury$125,618
K08 · FY2005 · HL
Calcineurin Inhibition: Lung Reperfusion Injury$125,618
K08 · FY2004 · HL
Calcineurin Inhibition: Lung Reperfusion Injury$125,618
K08 · FY2003 · HL
Calcineurin Inhibition: Lung Reperfusion Injury$125,418
K08 · FY2002 · HL